Temozolomide Plus PEG-Interferon Alfa-2B in Treating Patients With Advanced Solid Tumors
Clinical trial NCT00014261 · COMPLETED
Trial details
- NCT number
- NCT00014261
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2000-10-01
- Primary completion
- 2002-11-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.